S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.21
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.51
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
EOLS · Evolus, Inc.
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
$7.41
+0.04
(+0.61%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$7.41
$7.29
$7.42
52-WEEK RANGE
$7.41
$3.86
$9.31
What's happening
- EOLS is up 0.61% today, trading at $7.41. — Live quote
- Volume today (53,991) is well below its 3-month average of 864,510. (Finnhub fundamentals)
- Reports earnings on 2026-11-10, 19 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $0.02 actual vs. $-0.04 estimated (+156.8%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 5
Buy 5
Hold 2
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (12 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
EOLS
+10.83%
vs S&P 500
-1.95%
1-YEAR RETURN
EOLS
+10.16%
vs S&P 500
-4.40%
6-MONTH RETURN
EOLS
+62.69%
3-MONTH RETURN
EOLS
+26.96%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$0.02
Est. $-0.04
BEAT +156.8%
2026-04-26 (Q1 2026)
$-0.05
Est. $-0.13
BEAT +62.3%
2026-01-26 (Q4 2025)
$0.05
Est. $0.05
MISS -2.0%
2025-10-26 (Q3 2025)
$-0.11
Est. $-0.18
BEAT +37.5%
Valuation Measures & Ratios
Enterprise Value4$605.0M
Forward P/E552.64
PEG Ratio6—
Price / Sales (TTM1)1.56
Price / Book7126.60
EV4 / Revenue1.91
EV4 / EBITDA—
Profit Margin-10.85%
Operating Margin-5.90%
Return on Equity (ROE8)-410.18%
Return on Assets (ROA9)-15.03%
Avg Volume (3M)864,510
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $465.3M | $274.2M | $403.3M | $584.7M | $756.9M |
| P/E | -9.02 | -4.39 | -5.68 | -8.79 | -12.11 |
| Price/Sales | 1.57 | 0.98 | 1.50 | 2.20 | 2.96 |
| Price/Book | -15.06 | -9.53 | -14.02 | -31.35 | -114.62 |
| EV/Revenue | 1.95 | 1.36 | 1.89 | 2.51 | 2.69 |
| EV/EBITDA | -23.33 | -10.54 | -10.99 | — | — |
| ROE | 166.99% | 216.97% | 246.67% | 356.82% | 946.71% |
| ROA | -20.81% | -28.30% | -32.39% | -29.09% | -29.30% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short5,628,168
Change from Prior Settlement+1.76%
% of Float—
Days to Cover (Short Ratio)9.33
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 21.2% on the provider's reported measure. Finnhub fundamentals ↗
- Trailing 52-week price return is +10.2%. Finnhub market metrics ↗
Potential concerns
- Net profit margin is -10.8%. Finnhub fundamentals ↗
- Latest SEC filing is Form 4, filed 2026-09-04; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on EOLS
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $84.1M | $73.1M | $69.0M | $69.4M | $68.5M | $61.1M | $66.9M | $59.3M |
| Gross profit | $57.2M | $48.9M | $45.8M | $45.3M | $46.7M | $42.1M | $47.1M | $40.5M |
| Operating income | -$4.5M | -$6.8M | -$11.5M | -$10.2M | -$15.2M | -$15.5M | -$7.7M | -$8.9M |
| Net income | -$8.1M | -$10.7M | -$15.7M | -$17.1M | -$18.9M | -$19.2M | -$11.3M | -$13.1M |
| EPS (diluted) | $-0.12 | $-0.16 | $-0.24 | $-0.27 | $-0.30 | $-0.30 | $-0.18 | $-0.22 |
| EPS (basic) | $-0.12 | $-0.16 | $-0.24 | $-0.27 | $-0.30 | $-0.30 | $-0.18 | $-0.22 |
| Operating margin | -$5 | -$9 | -$17 | -$15 | -$22 | -$25 | -$12 | -$15 |
| Net margin | -$10 | -$15 | -$23 | -$25 | -$28 | -$31 | -$17 | -$22 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $248.0M | $220.6M | $225.9M | $219.0M | $228.8M | $213.4M | $232.6M | $229.6M |
| Total liabilities | $278.9M | $249.4M | $249.0M | $247.8M | $247.5M | $220.0M | $227.0M | $223.7M |
| Stockholders' equity | -$30.9M | -$28.8M | -$23.1M | -$28.8M | -$18.7M | -$6.6M | $5.5M | $5.9M |
| Total current assets | $167.5M | $138.9M | $142.9M | $134.9M | $145.0M | $131.7M | $151.3M | $150.4M |
| Total current liabilities | $98.7M | $68.0M | $75.3M | $66.7M | $63.8M | $56.2M | $63.0M | $60.8M |
| Cash & equivalents | $45.2M | $49.8M | $53.8M | $43.5M | $61.7M | $67.9M | $87.0M | $85.0M |
| Accounts receivable | $62.4M | $52.2M | $54.7M | $50.4M | $47.7M | $47.5M | $47.7M | $44.6M |
| Inventory | $40.9M | $24.8M | $27.0M | $32.9M | $26.5M | $10.0M | $12.2M | $14.9M |
| Other current assets | $14.6M | $7.5M | $3.7M | $3.5M | $4.3M | $2.9M | $1.2M | $2.4M |
| Property, plant & equipment | $5.0M | $5.3M | $5.4M | $5.1M | $3.7M | $3.3M | $3.2M | $2.3M |
| Goodwill | $21.2M | $21.2M | $21.2M | $21.2M | $21.2M | $21.2M | $21.2M | $21.2M |
| Intangible assets | $45.7M | $46.7M | $48.0M | $48.7M | $49.3M | $49.4M | $48.8M | $46.6M |
| Other non-current assets | $2.1M | $1.6M | $1.2M | $1.6M | $1.8M | $900.0K | $858.0K | $858.0K |
| Accounts payable | $44.5M | $19.5M | $23.4M | $23.0M | $23.3M | $16.2M | $9.2M | $13.8M |
| Accrued liabilities | $37.7M | $31.9M | $35.6M | $30.5M | $27.9M | $26.6M | $40.8M | $34.9M |
| Deferred revenue (current) | $11.6M | $8.6M | $11.5M | $8.6M | $8.7M | $7.6M | $14.5M | $13.2M |
| Long-term debt | $156.7M | $156.4M | $146.1M | $145.8M | $145.5M | — | $121.5M | — |
| Common stock & paid-in capital | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K |
| Retained earnings | -$679.8M | -$671.7M | -$661.0M | -$661.2M | -$645.4M | -$628.3M | -$609.4M | -$602.6M |
| Accumulated other comprehensive income (loss) | -$529.0K | -$278.0K | -$156.0K | -$137.0K | -$599.0K | -$839.0K | -$905.0K | -$689.0K |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$3.6M | -$10.0M | $12.8M | -$14.7M | -$24.8M | -$15.6M | $4.8M | -$5.7M |
| Investing cash flow | -$500.0K | -$1.7M | -$2.2M | -$2.2M | -$2.3M | -$1.9M | -$1.4M | -$1.4M |
| Financing cash flow | -$365.0K | $7.6M | $77.0K | -$1.8M | $20.7M | -$1.6M | -$1.3M | -$1.4M |
| Free cash flow | -$3.6M | -$10.4M | $11.3M | -$15.6M | -$25.5M | -$16.0M | $4.4M | -$6.0M |
| Capital expenditures | $50.0K | $415.0K | $1.5M | $955.0K | $688.0K | $319.0K | $438.0K | $313.0K |
| Depreciation & amortization | $2.3M | $2.3M | $2.3M | $2.0M | $1.7M | $1.6M | $1.4M | $1.1M |
| Share-based compensation | $5.6M | $5.1M | $5.1M | $5.1M | $4.5M | $5.9M | $6.2M | $5.2M |
| Deferred income taxes | -$584.0K | -$5.0K | $27.0K | -$21.0K | $20.0K | -$5.0K | -$23.0K | $0 |
| Change in accounts receivable | $10.9M | -$2.2M | $4.8M | $4.9M | $958.0K | $823.0K | $3.8M | $2.4M |
| Change in inventory | $1.3M | -$6.4M | -$4.7M | $11.5M | $8.3M | -$4.0M | -$979.0K | $1.5M |
| Change in accounts payable | $2.6M | -$7.6M | $2.0M | $4.1M | -$777.0K | $4.7M | -$2.9M | $3.5M |
| Purchases of investments | — | — | — | — | — | — | — | — |
| Debt issued | — | $10.0M | — | — | — | $0 | $0 | $0 |
| Debt repaid | — | — | — | — | — | — | — | — |
| Tax withholding on stock comp | — | $0 | -$8.0K | — | — | $8.0K | $990.0K | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $297.2M | $266.3M | $202.1M | $148.6M | $99.7M |
| Gross profit | $197.1M | $182.3M | $137.6M | $89.8M | — |
| Operating income | -$32.7M | -$34.4M | -$49.2M | -$65.3M | -$44.4M |
| Net income | -$51.6M | -$50.4M | -$61.7M | -$74.4M | -$46.8M |
| EPS (diluted) | $-0.80 | $-0.81 | $-1.08 | $-1.33 | $-0.94 |
| EPS (basic) | $-0.80 | $-0.81 | $-1.08 | $-1.33 | $-0.94 |
| Operating margin | -$11 | -$13 | -$24 | -$44 | -$45 |
| Net margin | -$17 | -$19 | -$31 | -$50 | -$47 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $225.9M | $232.6M | $189.0M | $178.0M | $257.5M |
| Total liabilities | $249.0M | $227.0M | $209.7M | $159.5M | $175.6M |
| Stockholders' equity | -$23.1M | $5.5M | -$20.7M | $18.5M | $81.9M |
| Total current assets | $142.9M | $151.3M | $112.4M | $100.8M | $178.8M |
| Total current liabilities | $75.3M | $63.0M | $48.3M | $46.5M | $57.7M |
| Cash & equivalents | $53.8M | $87.0M | $62.8M | $53.9M | $146.3M |
| Accounts receivable | $54.7M | $47.7M | $30.5M | $22.4M | $14.7M |
| Inventory | $27.0M | $12.2M | $11.0M | $18.9M | $1.8M |
| Other current assets | $3.7M | $1.2M | $2.4M | $1.7M | $11.0M |
| Property, plant & equipment | $5.4M | $3.2M | $2.1M | $2.6M | $1.4M |
| Goodwill | $21.2M | $21.2M | $21.2M | $21.2M | $21.2M |
| Intangible assets | $48.0M | $48.8M | $47.1M | $48.6M | $50.6M |
| Other non-current assets | $1.2M | $858.0K | $409.0K | $2.8M | $2.8M |
| Accounts payable | $23.4M | $9.2M | $4.3M | $8.9M | $6.1M |
| Accrued liabilities | $35.6M | $40.8M | $33.8M | $24.8M | $30.0M |
| Deferred revenue (current) | $11.5M | $14.5M | $11.0M | $9.0M | $7.9M |
| Long-term debt | — | — | — | — | — |
| Common stock & paid-in capital | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K |
| Retained earnings | -$661.0M | -$609.4M | -$559.0M | -$497.3M | -$422.9M |
| Accumulated other comprehensive income (loss) | -$156.0K | -$905.0K | -$427.0K | -$337.0K | $0 |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$42.3M | -$18.0M | -$34.0M | -$84.9M | -$33.4M |
| Investing cash flow | -$8.5M | -$4.8M | -$1.6M | -$2.9M | $4.0M |
| Financing cash flow | $17.3M | $47.4M | $44.6M | -$4.1M | $73.1M |
| Free cash flow | -$45.7M | -$19.5M | -$34.5M | -$86.5M | -$33.8M |
| Capital expenditures | $3.4M | $1.5M | $473.0K | $1.6M | $393.0K |
| Depreciation & amortization | $7.5M | $5.3M | $5.1M | $3.7M | $5.6M |
| Share-based compensation | $20.7M | $22.3M | $16.5M | $10.8M | $9.6M |
| Deferred income taxes | $21.0K | -$21.0K | $5.0K | -$18.0K | $15.0K |
| Change in accounts receivable | $11.5M | $19.6M | $9.5M | $9.4M | $5.6M |
| Change in inventory | $11.1M | -$3.3M | -$4.2M | $10.7M | $3.0M |
| Change in accounts payable | $10.1M | $391.0K | -$1.0M | $968.0K | -$787.0K |
| Purchases of investments | — | — | — | — | $0 |
| Debt issued | — | $0 | $50.0M | $0 | — |
| Debt repaid | — | — | — | — | $0 |
| Tax withholding on stock comp | $0 | $990.0K | $7.0K | $0 | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding EOLS as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Source: Business Quant SEC Form 13F · report period 2026-06-30 · 31 filers
Held by These Filers66.0%
Shares Outstanding65,929,112
| Filer | Shares | Value | % Out | Qtr Change | Filed |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 5,602,021 | $38.9M | 8.50% | -12.2% | 2026-08-14 |
| BlackRock, Inc. | 4,840,828 | $33.6M | 7.34% | +12.8% | 2026-08-07 |
| BRAIDWELL LP | 3,155,209 | $21.9M | 4.79% | +1.6% | 2026-08-14 |
| Frazier Life Sciences Management, L.P. | 2,630,665 | $18.3M | 3.99% | +0.0% | 2026-08-14 |
| PERCEPTIVE ADVISORS LLC | 2,459,285 | $17.1M | 3.73% | +91.1% | 2026-08-14 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,362,893 | $16.4M | 3.58% | -4.4% | 2026-06-30 |
| MILLENNIUM MANAGEMENT LLC | 1,787,929 | $12.4M | 2.71% | +22.4% | 2026-08-14 |
| State Street Corp | 1,697,294 | $11.8M | 2.57% | +28.5% | 2026-08-07 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,608,394 | $11.2M | 2.44% | +16.4% | 2026-08-12 |
| Stonepine Capital Management, LLC | 1,590,162 | $11.0M | 2.41% | -9.6% | 2026-08-14 |
| Point72 Asset Management, L.P. | 1,508,518 | $10.5M | 2.29% | +0.0% | 2026-08-14 |
| PINNACLE ASSOCIATES LTD | 1,487,264 | $10.3M | 2.26% | +28.3% | 2026-08-03 |
| ARMISTICE CAPITAL, LLC | 1,436,000 | $10.0M | 2.18% | +2.9% | 2026-08-14 |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,289,888 | $9.0M | 1.96% | +2.8% | 2026-08-07 |
| Goldman Sachs Group Inc | 1,219,419 | $8.5M | 1.85% | +12.2% | 2026-08-14 |
| Assenagon Asset Management S.A. | 908,180 | $6.3M | 1.38% | +51.8% | 2026-07-08 |
| Soleus Capital Management, L.P. | 822,428 | $5.7M | 1.25% | -63.4% | 2026-08-11 |
| Soviero Asset Management, LP | 770,000 | $5.3M | 1.17% | +13.2% | 2026-08-14 |
| UBS Group AG | 752,679 | $5.2M | 1.14% | -0.0% | 2026-08-13 |
| AWH Capital, L.P. | 625,000 | $4.3M | 0.95% | +0.0% | 2026-08-14 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 545,702 | $3.8M | 0.83% | +14.4% | 2026-06-30 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 530,843 | $3.7M | 0.81% | +3.0% | 2026-08-14 |
| Sixth Street Partners Management Company, L.P. | 530,843 | $3.7M | 0.81% | +0.0% | 2026-08-13 |
| CITADEL ADVISORS LLC | 506,354 | $3.5M | 0.77% | -27.3% | 2026-08-14 |
| Northern Trust Corp | 497,018 | $3.4M | 0.75% | +5.2% | 2026-08-12 |
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-03-18 to 2026-09-02
Recent transactions
- Insiders have net sold 105,108 shares over the last 182 days, across 0 purchases and 1 sale.
- Most recent: MOATAZEDI DAVID (See Remarks) — Open market sale of 105,108 shares on 2026-09-02.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)105,108 sh(1 txns)
Net Shares-105,108
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| MOATAZEDI DAVID | See Remarks | Open market sale | 2026-09-02 | 105,108 |
| Avelar Rui | See Remarks | Open market sale | 2026-03-20 | 3,119 |
| Parschauer Karah Herdman | Director | Grant / award | 2026-02-17 | 45,559 |
| Stewart Brady | Director | Grant / award | 2026-02-17 | 45,559 |
| Mitchell Tatjana | Chief Financial Officer | Grant / award | 2026-02-17 | 121,489 |
| White Albert G III | Director | Grant / award | 2026-02-17 | 45,559 |
| Malik Vikram | Director | Grant / award | 2026-02-17 | 45,559 |
| GILL DAVID N | Director | Grant / award | 2026-02-17 | 45,559 |
| Yamagishi-Dressler Tomoko | Chief Marketing Officer | Open market sale | 2025-08-22 | 5,722 |
| Beaver Sandra | Chief Financial Officer | Open market sale | 2025-05-13 | 6,494 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-02 | MOATAZEDI DAVID | See Remarks | Open market sale | 105,108 | $9.04 |
| 2026-03-20 | Avelar Rui | See Remarks | Open market sale | 3,119 | $4.75 |
| 2026-03-20 | MOATAZEDI DAVID | See Remarks | Open market sale | 13,669 | $4.75 |
| 2026-03-17 | MOATAZEDI DAVID | See Remarks | Open market sale | 116,720 | $4.89 |
| 2026-03-17 | Avelar Rui | See Remarks | Open market sale | 29,996 | $4.89 |
| 2026-03-16 | MOATAZEDI DAVID | See Remarks | Option exercise | 67,489 | $0.00 |
| 2026-03-16 | Avelar Rui | See Remarks | Option exercise | 8,804 | $0.00 |
| 2026-02-17 | Parschauer Karah Herdman | Director | Grant / award | 45,559 | $0.00 |
| 2026-02-17 | Stewart Brady | Director | Grant / award | 45,559 | $0.00 |
| 2026-02-17 | Mitchell Tatjana | Chief Financial Officer | Grant / award | 121,489 | $0.00 |
| 2026-02-17 | White Albert G III | Director | Grant / award | 45,559 | $0.00 |
| 2026-02-17 | MOATAZEDI DAVID | See Remarks | Grant / award | 313,212 | $0.00 |
| 2026-02-17 | Malik Vikram | Director | Grant / award | 45,559 | $0.00 |
| 2026-02-17 | Avelar Rui | See Remarks | Grant / award | 94,913 | $0.00 |
| 2026-02-17 | GILL DAVID N | Director | Grant / award | 45,559 | $0.00 |
| 2025-12-22 | MOATAZEDI DAVID | See Remarks | Open market sale | 10,539 | $7.15 |
| 2025-12-22 | Avelar Rui | See Remarks | Open market sale | 2,261 | $7.15 |
| 2025-09-08 | Mitchell Tatjana | Chief Financial Officer | Grant / award | 104,603 | $0.00 |
| 2025-08-22 | Yamagishi-Dressler Tomoko | Chief Marketing Officer | Open market sale | 5,722 | $7.51 |
| 2025-08-15 | Stewart Brady | Director | Open market purchase | 30,000 | $6.82 |
| 2025-06-16 | MOATAZEDI DAVID | See Remarks | Open market sale | 16,582 | $9.89 |
| 2025-06-13 | MOATAZEDI DAVID | See Remarks | Open market sale | 111,323 | $10.05 |
| 2025-06-09 | White Albert G III | Director | Open market purchase | 20,000 | $9.45 |
| 2025-05-13 | Beaver Sandra | Chief Financial Officer | Open market sale | 6,494 | $10.02 |
| 2025-05-12 | Avelar Rui | See Remarks | Open market sale | 3,385 | $9.87 |
| 2025-05-12 | MOATAZEDI DAVID | See Remarks | Open market sale | 15,787 | $9.87 |
| 2025-03-27 | MOATAZEDI DAVID | See Remarks | Open market sale | 6,251 | $12.40 |
| 2025-03-18 | Avelar Rui | See Remarks | Open market sale | 27,904 | $13.26 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 02:59 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-09-04 | 4 | 2026-09-02 | View on SEC.gov → |
| 2026-08-05 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-05 | 8-K | 2026-08-05 | View on SEC.gov → |
| 2026-08-04 | 8-K | 2026-08-03 | View on SEC.gov → |
| 2026-07-08 | 8-K | 2026-07-07 | View on SEC.gov → |
| 2026-06-12 | 8-K | 2026-06-11 | View on SEC.gov → |
| 2026-05-04 | 10-Q | 2026-03-31 | View on SEC.gov → |
| 2026-05-04 | 8-K | 2026-05-04 | View on SEC.gov → |
| 2026-03-20 | 4 | 2026-03-20 | View on SEC.gov → |
| 2026-03-20 | 4 | 2026-03-20 | View on SEC.gov → |
| 2026-03-18 | 4 | 2026-03-16 | View on SEC.gov → |
| 2026-03-18 | 4 | 2026-03-16 | View on SEC.gov → |
Recent news
Headlines about EOLS (Evolus, Inc.). Links open the publisher — we don’t host full articles.
-
Evolus to Report Third Quarter Financial Results on November 4, 2026
Yahoo · 2026-10-21 -
Evolus, Inc. (EOLS) Investigation: Bronstein, Gewirtz & Grossman
The National Law Review · 2026-10-20 -
EOLS261120P00005000 interactive stock chart | EOLS Nov 2026 5.000 put stock
Yahoo Finance Australia · 2026-10-17 -
EOLS Nov 2026 10.000 call (EOLS261120C00010000) stock price, news, quote and history
Yahoo Finance Australia · 2026-10-17 -
EOLS270115P00010000 interactive stock chart | EOLS Jan 2027 10.000 put stock
Yahoo Finance Australia · 2026-10-17 -
Evolus, Inc. (EOLS) stock price, news, quote and history
Yahoo Finance Australia · 2026-10-15 -
Evolus Expands Innovation Pipeline with Novel Injectable Hair Restoration Program
Yahoo · 2026-10-14 -
UTMD Trades at a Premium to the Industry: How to Play the Stock?
Yahoo · 2026-10-08
No headlines in this category right now — try “All”.